Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland · Delayed Price · Currency is CHF 54.70
+0.30 (0.55%)
Apr 1, 2026, 5:30 PM CET
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 668.66 million as of April 1, 2026. Its market cap has increased by 16.42% in one year.
Market Cap
668.66M
Enterprise Value
598.08M
Revenue
232.38M
Ranking
n/a
PE Ratio
17.31
Stock Price
54.70
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 668.66M, an increase of 25.38%. That is a compound annual growth rate of 1.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 672.35M | 0.03% |
| Dec 30, 2025 | 672.13M | 34.10% |
| Dec 30, 2024 | 501.21M | 18.52% |
| Dec 29, 2023 | 422.90M | -22.52% |
| Dec 30, 2022 | 545.84M | 12.62% |
| Dec 30, 2021 | 484.67M | -15.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 835.00M |
| Newron Pharmaceuticals | 310.67M |
| Santhera Pharmaceuticals Holding AG | 211.40M |
| BioVersys AG | 169.59M |
| Xlife Sciences AG | 118.24M |
| Molecular Partners AG | 117.47M |
| EvoNext Holdings | 5.91M |
| Addex Therapeutics | 5.13M |